| Previous Close | 1.36 |
| Open | 1.35 |
| Bid | 1.22 x 1000 |
| Ask | 1.49 x 1000 |
| Day's Range | 1.27 - 1.36 |
| 52 Week Range | 0.67 - 5.10 |
| Volume | 1,443,775 |
| Avg. Volume | 3,641,477 |
| Market Cap | 131.31M |
| Beta | 2.81 |
| PE Ratio (TTM) | 0.92 |
| EPS (TTM) | 1.41 |
| Earnings Date | Mar 13, 2017 - Mar 17, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.54 |
- GlobeNewswire•6 days ago
Steven Binder Joins MannKind as Chief Financial Officer
VALENCIA, Calif., July 17, 2017-- MannKind Corporation today announced that Steven Binder has joined the company as its Chief Financial Officer with full responsibilities for leading MannKind’ s finance, ...
- Accesswire•9 days ago
Today's Research Reports on Stocks to Watch: Mannkind Corporation and AstraZeneca
NEW YORK, NY / ACCESSWIRE / July 14, 2017 / AstraZeneca;s shares took a tumble yesterday as traders learned the compan'’s CEO has accepted a position at TEVA, an Israeli-based genetics company. Many investors ...
- Zacks•10 days ago
Options Traders Expect Huge Moves in MannKind (MNKD) Stock
MannKind (MNKD) needs investors to pay close attention to the stock based on moves in the options market lately.
